Escherichia coli Infections

"Escherichia coli Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Infections with bacteria of the species ESCHERICHIA COLI.

Descriptor ID	D004927
MeSH Number(s)	C01.252.400.310.330
Concept/Terms	Escherichia coli Infections Escherichia coli Infections E coli Infections E coli Infection Infection, E coli Infections, Escherichia coli Escherichia coli Infection Infection, Escherichia coli E. coli Infection E. coli Infections Infection, E. coli Infections, E coli

Below are MeSH descriptors whose meaning is more general than "Escherichia coli Infections".

Diseases [C]
Bacterial Infections and Mycoses [C01]
Bacterial Infections [C01.252]
Gram-Negative Bacterial Infections [C01.252.400]
Enterobacteriaceae Infections [C01.252.400.310]
Escherichia coli Infections [C01.252.400.310.330]

Below are MeSH descriptors whose meaning is related to "Escherichia coli Infections".

Below are MeSH descriptors whose meaning is more specific than "Escherichia coli Infections".

Escherichia coli Infections
Meningitis, Escherichia coli

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Escherichia coli Infections" by people in this website by year, and whether "Escherichia coli Infections" was a major or minor topic of these publications.

Bar chart showing 54 publications over 25 distinct years, with a maximum of 7 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	0	1
1995	1	0	1
1998	0	1	1
1999	0	1	1
2001	1	1	2
2003	0	1	1
2004	1	0	1
2005	2	0	2
2006	0	1	1
2007	1	3	4
2008	1	0	1
2009	2	1	3
2010	2	0	2
2011	3	0	3
2012	4	3	7
2013	1	0	1
2014	2	1	3
2015	5	0	5
2017	3	2	5
2018	2	0	2
2019	1	1	2
2020	1	0	1
2021	1	1	2
2022	1	0	1
2023	1	0	1

Below are the most recent publications written about "Escherichia coli Infections" by people in Profiles.

Bajoria S, Antunez LR, Kumru OS, Klempner M, Wang Y, Cavacini LA, Joshi SB, Volkin DB. Formulation Studies to Develop Low-Cost, Orally-Delivered Secretory IgA Monoclonal Antibodies for Passive Immunization Against Enterotoxigenic Escherichia coli. J Pharm Sci. 2023 07; 112(7):1832-1844.

View in: PubMed
Mortzfeld BM, Palmer JD, Bhattarai SK, Dupre HL, Mercado-Lubio R, Silby MW, Bang C, McCormick BA, Bucci V. Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic. Gut Microbes. 2022 Jan-Dec; 14(1):2127633.

View in: PubMed
Amcheslavsky A, Wallace AL, Ejemel M, Li Q, McMahon CT, Stoppato M, Giuntini S, Schiller ZA, Pondish JR, Toomey JR, Schneider RM, Meisinger J, Heukers R, Kruse AC, Barry EM, Pierce BG, Klempner MS, Cavacini LA, Wang Y. Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design. Sci Rep. 2021 02 02; 11(1):2751.

View in: PubMed
Teh AY, Cavacini L, Hu Y, Kumru OS, Xiong J, Bolick DT, Joshi SB, Gr?nwald-Gruber C, Altmann F, Klempner M, Guerrant RL, Volkin DB, Wang Y, Ma JK. Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants. Gut Microbes. 2021 Jan-Dec; 13(1):1-14.

View in: PubMed
Stoppato M, Gaspar C, Regeimbal J, Nunez RG, Giuntini S, Schiller ZA, Gawron MA, Pondish JR, Martin JC, Schneider MI, Klempner MS, Cavacini LA, Wang Y. Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model. Vaccine. 2020 02 28; 38(10):2333-2339.

View in: PubMed
Hu Y, Kumru OS, Xiong J, Antunez LR, Hickey J, Wang Y, Cavacini L, Klempner M, Joshi SB, Volkin DB. Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration. J Pharm Sci. 2020 01; 109(1):407-421.

View in: PubMed
Roy SM, Riley MA. Evaluation of the potential of colicins to prevent extraluminal contamination of urinary catheters by Escherichia coli. Int J Antimicrob Agents. 2019 Nov; 54(5):619-625.

View in: PubMed
Ben-Chetrit E, Eldaim MA, Bar-Meir M, Dodin M, Katz DE. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia. Int J Antimicrob Agents. 2019 Apr; 53(4):423-428.

View in: PubMed
Giuntini S, Stoppato M, Sedic M, Ejemel M, Pondish JR, Wisheart D, Schiller ZA, Thomas WD, Barry EM, Cavacini LA, Klempner MS, Wang Y. Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection. Infect Immun. 2018 08; 86(8).

View in: PubMed
Gupta A, Das R, Yesilbag Tonga G, Mizuhara T, Rotello VM. Charge-Switchable Nanozymes for Bioorthogonal Imaging of Biofilm-Associated Infections. ACS Nano. 2018 01 23; 12(1):89-94.

View in: PubMed

People

Explore

Similar Concepts

Top Journals